BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30718148)

  • 1. Circulating Levels of Soluble Klotho and Fibroblast Growth Factor 23 in Diabetic Patients and Its Association with Early Nephropathy.
    Farías-Basulto A; Martínez-Ramírez HR; Gómez-García EF; Cueto-Manzano AM; Cortés-Sanabria L; Hernández-Ramos LE; Ramírez-López G; Mendoza-Carrera F
    Arch Med Res; 2018 Oct; 49(7):451-455. PubMed ID: 30718148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Klotho levels: association with insulin resistance and albumin-to-creatinine ratio in type 2 diabetic patients.
    Silva AP; Mendes F; Pereira L; Fragoso A; Gonçalves RB; Santos N; Rato F; Neves PL
    Int Urol Nephrol; 2017 Oct; 49(10):1809-1814. PubMed ID: 28677090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
    Kacso IM; Bondor CI; Kacso G
    Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease.
    Ribeiro AL; Mendes F; Carias E; Rato F; Santos N; Neves PL; Silva AP
    J Diabetes Complications; 2020 Jan; 34(1):107476. PubMed ID: 31708378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
    Manou E; Thodis E; Arsos G; Pasadakis P; Panagoutsos S; Papadopoulou D; Papagianni A
    Kidney Blood Press Res; 2020; 45(6):900-915. PubMed ID: 33040068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble Klotho and fibroblast growth factor 23 levels in diabetic nephropathy with different stages of albuminuria.
    Inci A; Sari F; Coban M; Olmaz R; Dolu S; Sarıkaya M; Yılmaz N
    J Investig Med; 2016 Aug; 64(6):1128-33. PubMed ID: 27323770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of nephrectomy on Klotho, FGF-23 and bone metabolism.
    Kakareko K; Rydzewska-Rosolowska A; Brzosko S; Gozdzikiewicz-Lapinska J; Koc-Zorawska E; Samocik P; Kozlowski R; Mysliwiec M; Naumnik B; Hryszko T
    Int Urol Nephrol; 2017 Apr; 49(4):681-688. PubMed ID: 28130714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between serum fibroblast growth factor 21 and diabetic nephropathy.
    Jian WX; Peng WH; Jin J; Chen XR; Fang WJ; Wang WX; Qin L; Dong Y; Su Q
    Metabolism; 2012 Jun; 61(6):853-9. PubMed ID: 22136913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
    Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23.
    Scholze A; Liu Y; Pedersen L; Xia S; Roth HJ; Hocher B; Rasmussen LM; Tepel M
    J Clin Endocrinol Metab; 2014 May; 99(5):E855-61. PubMed ID: 24606097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor-23 but not sKlotho levels are related to diastolic dysfunction in type 1 diabetic patients with early diabetic nephropathy.
    Dogan B; Arikan IH; Guler D; Keles N; Isbilen B; Isman F; Oguz A
    Int Urol Nephrol; 2016 Mar; 48(3):399-407. PubMed ID: 26759325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MORPHOGENETIC PROTEINS--FIBROBLAST GROWTH FACTOR AND KLOTHO, IN THE SERA OF PATIENTS WITH CHRONIC RENAL DISEASE].
    Milovanova LY; Kozlovskaya LV; Markina MM; Milovanova SY; Borisov AA; Mukhin NA; Fomin VV; Moiseev SV
    Klin Med (Mosk); 2015; 93(12):32-8. PubMed ID: 27149811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
    Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
    Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients.
    Silva AP; Mendes F; Carias E; Gonçalves RB; Fragoso A; Dias C; Tavares N; Café HM; Santos N; Rato F; Leão Neves P; Almeida E
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus.
    Nie F; Wu D; Du H; Yang X; Yang M; Pang X; Xu Y
    J Diabetes Complications; 2017 Mar; 31(3):594-598. PubMed ID: 27916483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease.
    Navarro-González JF; Sánchez-Niño MD; Donate-Correa J; Martín-Núñez E; Ferri C; Pérez-Delgado N; Górriz JL; Martínez-Castelao A; Ortiz A; Mora-Fernández C
    Diabetes Care; 2018 Aug; 41(8):1817-1820. PubMed ID: 29866645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease].
    Milovanova LIu; Milovanov IuS; Kozlovskaia LV; Mukhin NA
    Ter Arkh; 2014; 86(4):36-44. PubMed ID: 24864466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.